Share Email Print
cover

Proceedings Paper

Design of programmable multilayered nanoparticles with in situ manufacture of therapeutic genes for nanomedicine
Author(s): Mary-Margaret Seale; Emily Haglund; Christy L. Cooper; Lisa M. Reece; James F. Leary
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Nanomedicine focuses on a new approach to diagnostic and therapeutic strategies. Nanomedical systems distinguish between diseased and healthy cells on a single cell level and perform a programmed function when necessary. Current research in nanomedicine investigates the interaction of nanomedical systems with living systems in order to assess the biological effects both in the short and long term. The unique goal of the nanomedical system is to deliver a gene for in situ manufacturing of therapeutic agents for cellular repair. Treating cells on an individual level illustrates a paradigm shift created from nanotechnology.

Paper Details

Date Published: 6 February 2007
PDF: 7 pages
Proc. SPIE 6430, Advanced Biomedical and Clinical Diagnostic Systems V, 643003 (6 February 2007); doi: 10.1117/12.701619
Show Author Affiliations
Mary-Margaret Seale, Purdue Univ. (United States)
Emily Haglund, Purdue Univ. (United States)
Christy L. Cooper, Purdue Univ. (United States)
Lisa M. Reece, Purdue Univ. (United States)
James F. Leary, Purdue Univ. (United States)


Published in SPIE Proceedings Vol. 6430:
Advanced Biomedical and Clinical Diagnostic Systems V
Ramesh Raghavachari; Tuan Vo-Dinh; Warren S. Grundfest M.D.; David A. Benaron M.D.; Gerald E. Cohn, Editor(s)

© SPIE. Terms of Use
Back to Top
PREMIUM CONTENT
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?
close_icon_gray